Antibodies in Oncology Market - Global Outlook and Forecast 2021-2027

April 2021 | 90 pages | ID: A516F07AA008EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Antibodies in Oncology in Global, including the following market information:

Global Antibodies in Oncology Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Antibodies in Oncology market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Antibodies in Oncology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Antibodies in Oncology Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Antibodies in Oncology Market Segment Percentages, By Type, 2020 (%)

• Murine Antibodies
• Chimeric and Humanised Antibodies
• Fully Humanized Antibodies
• Others

China Antibodies in Oncology Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Antibodies in Oncology Market Segment Percentages, By Application, 2020 (%)

• Hospitals
• Academic Institutes
• Clinics

Global Antibodies in Oncology Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Antibodies in Oncology Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Antibodies in Oncology Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Antibodies in Oncology Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• Novartis International AG
• GlaxoSmithKline plc
• Biogen Idec Inc.
• Bristol Myers Squibb Co.
• AstraZeneca plc.
• Celltrion
• 3SBIO
• Celgen Biopharma
• Dr Reddy’s

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Antibodies in Oncology Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Antibodies in Oncology Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ANTIBODIES IN ONCOLOGY OVERALL MARKET SIZE

2.1 Global Antibodies in Oncology Market Size: 2021 VS 2027
2.2 Global Antibodies in Oncology Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Antibodies in Oncology Players in Global Market
3.2 Top Global Antibodies in Oncology Companies Ranked by Revenue
3.3 Global Antibodies in Oncology Revenue by Companies
3.4 Top 3 and Top 5 Antibodies in Oncology Companies in Global Market, by Revenue in 2020
3.5 Global Companies Antibodies in Oncology Product Type
3.6 Tier 1, Tier 2 and Tier 3 Antibodies in Oncology Players in Global Market
  3.6.1 List of Global Tier 1 Antibodies in Oncology Companies
  3.6.2 List of Global Tier 2 and Tier 3 Antibodies in Oncology Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Antibodies in Oncology Market Size Markets, 2021 & 2027
  4.1.2 Murine Antibodies
  4.1.3 Chimeric and Humanised Antibodies
  4.1.4 Fully Humanized Antibodies
  4.1.5 Others
4.2 By Type - Global Antibodies in Oncology Revenue & Forecasts
  4.2.1 By Type - Global Antibodies in Oncology Revenue, 2016-2021
  4.2.2 By Type - Global Antibodies in Oncology Revenue, 2022-2027
  4.2.3 By Type - Global Antibodies in Oncology Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Antibodies in Oncology Market Size, 2021 & 2027
  5.1.2 Hospitals
  5.1.3 Academic Institutes
  5.1.4 Clinics
5.2 By Application - Global Antibodies in Oncology Revenue & Forecasts
  5.2.1 By Application - Global Antibodies in Oncology Revenue, 2016-2021
  5.2.2 By Application - Global Antibodies in Oncology Revenue, 2022-2027
  5.2.3 By Application - Global Antibodies in Oncology Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Antibodies in Oncology Market Size, 2021 & 2027
6.2 By Region - Global Antibodies in Oncology Revenue & Forecasts
  6.2.1 By Region - Global Antibodies in Oncology Revenue, 2016-2021
  6.2.2 By Region - Global Antibodies in Oncology Revenue, 2022-2027
  6.2.3 By Region - Global Antibodies in Oncology Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Antibodies in Oncology Revenue, 2016-2027
  6.3.2 US Antibodies in Oncology Market Size, 2016-2027
  6.3.3 Canada Antibodies in Oncology Market Size, 2016-2027
  6.3.4 Mexico Antibodies in Oncology Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Antibodies in Oncology Revenue, 2016-2027
  6.4.2 Germany Antibodies in Oncology Market Size, 2016-2027
  6.4.3 France Antibodies in Oncology Market Size, 2016-2027
  6.4.4 U.K. Antibodies in Oncology Market Size, 2016-2027
  6.4.5 Italy Antibodies in Oncology Market Size, 2016-2027
  6.4.6 Russia Antibodies in Oncology Market Size, 2016-2027
  6.4.7 Nordic Countries Antibodies in Oncology Market Size, 2016-2027
  6.4.8 Benelux Antibodies in Oncology Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Antibodies in Oncology Revenue, 2016-2027
  6.5.2 China Antibodies in Oncology Market Size, 2016-2027
  6.5.3 Japan Antibodies in Oncology Market Size, 2016-2027
  6.5.4 South Korea Antibodies in Oncology Market Size, 2016-2027
  6.5.5 Southeast Asia Antibodies in Oncology Market Size, 2016-2027
  6.5.6 India Antibodies in Oncology Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Antibodies in Oncology Revenue, 2016-2027
  6.6.2 Brazil Antibodies in Oncology Market Size, 2016-2027
  6.6.3 Argentina Antibodies in Oncology Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Antibodies in Oncology Revenue, 2016-2027
  6.7.2 Turkey Antibodies in Oncology Market Size, 2016-2027
  6.7.3 Israel Antibodies in Oncology Market Size, 2016-2027
  6.7.4 Saudi Arabia Antibodies in Oncology Market Size, 2016-2027
  6.7.5 UAE Antibodies in Oncology Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Novartis International AG
  7.1.1 Novartis International AG Corporate Summary
  7.1.2 Novartis International AG Business Overview
  7.1.3 Novartis International AG Antibodies in Oncology Major Product Offerings
  7.1.4 Novartis International AG Antibodies in Oncology Revenue in Global (2016-2021)
  7.1.5 Novartis International AG Key News
7.2 GlaxoSmithKline plc
  7.2.1 GlaxoSmithKline plc Corporate Summary
  7.2.2 GlaxoSmithKline plc Business Overview
  7.2.3 GlaxoSmithKline plc Antibodies in Oncology Major Product Offerings
  7.2.4 GlaxoSmithKline plc Antibodies in Oncology Revenue in Global (2016-2021)
  7.2.5 GlaxoSmithKline plc Key News
7.3 Biogen Idec Inc.
  7.3.1 Biogen Idec Inc. Corporate Summary
  7.3.2 Biogen Idec Inc. Business Overview
  7.3.3 Biogen Idec Inc. Antibodies in Oncology Major Product Offerings
  7.3.4 Biogen Idec Inc. Antibodies in Oncology Revenue in Global (2016-2021)
  7.3.5 Biogen Idec Inc. Key News
7.4 Bristol Myers Squibb Co.
  7.4.1 Bristol Myers Squibb Co. Corporate Summary
  7.4.2 Bristol Myers Squibb Co. Business Overview
  7.4.3 Bristol Myers Squibb Co. Antibodies in Oncology Major Product Offerings
  7.4.4 Bristol Myers Squibb Co. Antibodies in Oncology Revenue in Global (2016-2021)
  7.4.5 Bristol Myers Squibb Co. Key News
7.5 AstraZeneca plc.
  7.5.1 AstraZeneca plc. Corporate Summary
  7.5.2 AstraZeneca plc. Business Overview
  7.5.3 AstraZeneca plc. Antibodies in Oncology Major Product Offerings
  7.5.4 AstraZeneca plc. Antibodies in Oncology Revenue in Global (2016-2021)
  7.5.5 AstraZeneca plc. Key News
7.6 Celltrion
  7.6.1 Celltrion Corporate Summary
  7.6.2 Celltrion Business Overview
  7.6.3 Celltrion Antibodies in Oncology Major Product Offerings
  7.6.4 Celltrion Antibodies in Oncology Revenue in Global (2016-2021)
  7.6.5 Celltrion Key News
7.7 3SBIO
  7.7.1 3SBIO Corporate Summary
  7.7.2 3SBIO Business Overview
  7.7.3 3SBIO Antibodies in Oncology Major Product Offerings
  7.4.4 3SBIO Antibodies in Oncology Revenue in Global (2016-2021)
  7.7.5 3SBIO Key News
7.8 Celgen Biopharma
  7.8.1 Celgen Biopharma Corporate Summary
  7.8.2 Celgen Biopharma Business Overview
  7.8.3 Celgen Biopharma Antibodies in Oncology Major Product Offerings
  7.8.4 Celgen Biopharma Antibodies in Oncology Revenue in Global (2016-2021)
  7.8.5 Celgen Biopharma Key News
7.9 Dr Reddy’s
  7.9.1 Dr Reddy’s Corporate Summary
  7.9.2 Dr Reddy’s Business Overview
  7.9.3 Dr Reddy’s Antibodies in Oncology Major Product Offerings
  7.9.4 Dr Reddy’s Antibodies in Oncology Revenue in Global (2016-2021)
  7.9.5 Dr Reddy’s Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Antibodies in Oncology Market Opportunities & Trends in Global Market
Table 2. Antibodies in Oncology Market Drivers in Global Market
Table 3. Antibodies in Oncology Market Restraints in Global Market
Table 4. Key Players of Antibodies in Oncology in Global Market
Table 5. Top Antibodies in Oncology Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Antibodies in Oncology Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Antibodies in Oncology Revenue Share by Companies, 2016-2021
Table 8. Global Companies Antibodies in Oncology Product Type
Table 9. List of Global Tier 1 Antibodies in Oncology Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Antibodies in Oncology Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Antibodies in Oncology Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Antibodies in Oncology Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Antibodies in Oncology Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Antibodies in Oncology Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Antibodies in Oncology Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Antibodies in Oncology Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Antibodies in Oncology Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Antibodies in Oncology Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Antibodies in Oncology Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Antibodies in Oncology Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Antibodies in Oncology Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Antibodies in Oncology Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Antibodies in Oncology Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Antibodies in Oncology Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Antibodies in Oncology Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Antibodies in Oncology Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Antibodies in Oncology Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Antibodies in Oncology Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Antibodies in Oncology Revenue, (US$, Mn), 2022-2027
Table 30. Novartis International AG Corporate Summary
Table 31. Novartis International AG Antibodies in Oncology Product Offerings
Table 32. Novartis International AG Antibodies in Oncology Revenue (US$, Mn), (2016-2021)
Table 33. GlaxoSmithKline plc Corporate Summary
Table 34. GlaxoSmithKline plc Antibodies in Oncology Product Offerings
Table 35. GlaxoSmithKline plc Antibodies in Oncology Revenue (US$, Mn), (2016-2021)
Table 36. Biogen Idec Inc. Corporate Summary
Table 37. Biogen Idec Inc. Antibodies in Oncology Product Offerings
Table 38. Biogen Idec Inc. Antibodies in Oncology Revenue (US$, Mn), (2016-2021)
Table 39. Bristol Myers Squibb Co. Corporate Summary
Table 40. Bristol Myers Squibb Co. Antibodies in Oncology Product Offerings
Table 41. Bristol Myers Squibb Co. Antibodies in Oncology Revenue (US$, Mn), (2016-2021)
Table 42. AstraZeneca plc. Corporate Summary
Table 43. AstraZeneca plc. Antibodies in Oncology Product Offerings
Table 44. AstraZeneca plc. Antibodies in Oncology Revenue (US$, Mn), (2016-2021)
Table 45. Celltrion Corporate Summary
Table 46. Celltrion Antibodies in Oncology Product Offerings
Table 47. Celltrion Antibodies in Oncology Revenue (US$, Mn), (2016-2021)
Table 48. 3SBIO Corporate Summary
Table 49. 3SBIO Antibodies in Oncology Product Offerings
Table 50. 3SBIO Antibodies in Oncology Revenue (US$, Mn), (2016-2021)
Table 51. Celgen Biopharma Corporate Summary
Table 52. Celgen Biopharma Antibodies in Oncology Product Offerings
Table 53. Celgen Biopharma Antibodies in Oncology Revenue (US$, Mn), (2016-2021)
Table 54. Dr Reddy’s Corporate Summary
Table 55. Dr Reddy’s Antibodies in Oncology Product Offerings
Table 56. Dr Reddy’s Antibodies in Oncology Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Antibodies in Oncology Segment by Type
Figure 2. Antibodies in Oncology Segment by Application
Figure 3. Global Antibodies in Oncology Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Antibodies in Oncology Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Antibodies in Oncology Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Antibodies in Oncology Revenue in 2020
Figure 8. By Type - Global Antibodies in Oncology Revenue Market Share, 2016-2027
Figure 9. By Application - Global Antibodies in Oncology Revenue Market Share, 2016-2027
Figure 10. By Region - Global Antibodies in Oncology Revenue Market Share, 2016-2027
Figure 11. By Country - North America Antibodies in Oncology Revenue Market Share, 2016-2027
Figure 12. US Antibodies in Oncology Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Antibodies in Oncology Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Antibodies in Oncology Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Antibodies in Oncology Revenue Market Share, 2016-2027
Figure 16. Germany Antibodies in Oncology Revenue, (US$, Mn), 2016-2027
Figure 17. France Antibodies in Oncology Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Antibodies in Oncology Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Antibodies in Oncology Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Antibodies in Oncology Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Antibodies in Oncology Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Antibodies in Oncology Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Antibodies in Oncology Revenue Market Share, 2016-2027
Figure 24. China Antibodies in Oncology Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Antibodies in Oncology Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Antibodies in Oncology Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Antibodies in Oncology Revenue, (US$, Mn), 2016-2027
Figure 28. India Antibodies in Oncology Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Antibodies in Oncology Revenue Market Share, 2016-2027
Figure 30. Brazil Antibodies in Oncology Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Antibodies in Oncology Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Antibodies in Oncology Revenue Market Share, 2016-2027
Figure 33. Turkey Antibodies in Oncology Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Antibodies in Oncology Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Antibodies in Oncology Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Antibodies in Oncology Revenue, (US$, Mn), 2016-2027
Figure 37. Novartis International AG Antibodies in Oncology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. GlaxoSmithKline plc Antibodies in Oncology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Biogen Idec Inc. Antibodies in Oncology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Bristol Myers Squibb Co. Antibodies in Oncology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. AstraZeneca plc. Antibodies in Oncology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Celltrion Antibodies in Oncology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. 3SBIO Antibodies in Oncology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Celgen Biopharma Antibodies in Oncology Revenue Year Over Year Growth (US$, Mn) & (2016-2021)